Piperaquine
Top View
- Drugs for Parasitic Infections (2013 Edition)
- Development of Copy Number Assays for Detection and Surveillance Of
- Piperaquine and Chloroquine Against Plasmodium Vivax Malaria, Cambodia
- Status Report on Artemisinin Resistance
- Identification of Trypanosoma Cruzi Growth Inhibitors with Activity In
- 210795Orig1s000
- Who-Pq Recommended Summary of Product Characteristics
- In Vitro Evaluation of the Antiviral Activity of Methylene Blue Alone Or in Combination Against SARS-Cov-2
- The Cardiotoxicity of Antimalarials
- And Aspirin- Mediated Protective Role of HSP70 and HSP90 As Modes to Strengthen the Natural Immunity Against Potent SARS-Cov-2
- COVID-19: Chloroquine and Hydroxychloroquine Research
- Download Author Version (PDF)
- WO 2007/028413 Al
- Lumefantrine and Piperaquine: Mechanisms of Resistance
- Eurartesim; INN: Piperaquine Tetraphosphate/Dihydroartemisinin
- Intravenous Artesunate Plus Oral Dihydroartemisinin–Piperaquine Or
- Mechanisms Associated with Trypanosoma Cruzi Host Target Cell Adhesion, Recognition and Internalization
- Choreoathetosis – an Unusual Adverse Effect of Dihydroartemisinin